[Clinical aspects of abuse drugs mainly used by adolescents].
Franceschini
E
E
Pediatra di famiglia, ASL 10, Florence, Italy.
Baronti
R
R
D000293:Adolescent; D000294:Adolescent Behavior; D000367:Age Factors; D019969:Amphetamine-Related Disorders / Q000175:diagnosis / Q000453:epidemiology; D000662:Amphetamines / Q000506:poisoning; D014151:Anti-Anxiety Agents / Q000506:poisoning; D002188:Cannabis / Q000506:poisoning; D003042:Cocaine / Q000506:poisoning; D019970:Cocaine-Related Disorders / Q000175:diagnosis / Q000453:epidemiology; D005445:Flunitrazepam / Q000506:poisoning; D006213:Hallucinogens / Q000506:poisoning; D006556:Heroin Dependence / Q000175:diagnosis / Q000453:epidemiology; D006801:Humans; D007558:Italy / Q000453:epidemiology; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000506:poisoning; D011041:Poisoning / Q000175:diagnosis* / Q000628:therapy*; D012997:Solvents / Q000506:poisoning; D019966:Substance-Related Disorders / Q000175:diagnosis* / Q000453:epidemiology*
D000662:Amphetamines; D014151:Anti-Anxiety Agents; D006213:Hallucinogens; D012997:Solvents; D005445:Flunitrazepam; D003042:Cocaine; D018817:N-Methyl-3,4-methylenedioxyamphetamine